172 related articles for article (PubMed ID: 21190543)
1. Synthetic LXR agonist suppresses endogenous cholesterol biosynthesis and efficiently lowers plasma cholesterol.
Pfeifer T; Buchebner M; Chandak PG; Patankar J; Kratzer A; Obrowsky S; Rechberger GN; Kadam RS; Kompella UB; Kostner GM; Kratky D; Levak-Frank S
Curr Pharm Biotechnol; 2011 Feb; 12(2):285-92. PubMed ID: 21190543
[TBL] [Abstract][Full Text] [Related]
2. Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia.
Kratzer A; Buchebner M; Pfeifer T; Becker TM; Uray G; Miyazaki M; Miyazaki-Anzai S; Ebner B; Chandak PG; Kadam RS; Calayir E; Rathke N; Ahammer H; Radovic B; Trauner M; Hoefler G; Kompella UB; Fauler G; Levi M; Levak-Frank S; Kostner GM; Kratky D
J Lipid Res; 2009 Feb; 50(2):312-26. PubMed ID: 18812595
[TBL] [Abstract][Full Text] [Related]
3. Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor.
Quinet EM; Savio DA; Halpern AR; Chen L; Miller CP; Nambi P
J Lipid Res; 2004 Oct; 45(10):1929-42. PubMed ID: 15292374
[TBL] [Abstract][Full Text] [Related]
4. Selective LXR agonist DMHCA corrects retinal and bone marrow dysfunction in type 2 diabetes.
Vieira CP; Fortmann SD; Hossain M; Longhini AL; Hammer SS; Asare-Bediako B; Crossman DK; Sielski MS; Adu-Agyeiwaah Y; Dupont M; Floyd JL; Li Calzi S; Lydic T; Welner RS; Blanchard GJ; Busik JV; Grant MB
JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32641586
[TBL] [Abstract][Full Text] [Related]
5.
El-Darzi N; Astafev A; Mast N; Saadane A; Lam M; Pikuleva IA
Front Pharmacol; 2018; 9():827. PubMed ID: 30090064
[No Abstract] [Full Text] [Related]
6. Studies on the cholesterol-free mouse: strong activation of LXR-regulated hepatic genes when replacing cholesterol with desmosterol.
Heverin M; Meaney S; Brafman A; Shafir M; Olin M; Shafaati M; von Bahr S; Larsson L; Lövgren-Sandblom A; Diczfalusy U; Parini P; Feinstein E; Björkhem I
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2191-7. PubMed ID: 17761942
[TBL] [Abstract][Full Text] [Related]
7. Liver X receptors preserve renal glomerular integrity under normoglycaemia and in diabetes in mice.
Patel M; Wang XX; Magomedova L; John R; Rasheed A; Santamaria H; Wang W; Tsai R; Qiu L; Orellana A; Advani A; Levi M; Cummins CL
Diabetologia; 2014 Feb; 57(2):435-46. PubMed ID: 24201575
[TBL] [Abstract][Full Text] [Related]
8. Desmosterol can replace cholesterol in sustaining cell proliferation and regulating the SREBP pathway in a sterol-Delta24-reductase-deficient cell line.
Rodríguez-Acebes S; de la Cueva P; Fernández-Hernando C; Ferruelo AJ; Lasunción MA; Rawson RB; Martínez-Botas J; Gómez-Coronado D
Biochem J; 2009 May; 420(2):305-15. PubMed ID: 19260826
[TBL] [Abstract][Full Text] [Related]
9. Liver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice.
Zhang Y; Breevoort SR; Angdisen J; Fu M; Schmidt DR; Holmstrom SR; Kliewer SA; Mangelsdorf DJ; Schulman IG
J Clin Invest; 2012 May; 122(5):1688-99. PubMed ID: 22484817
[TBL] [Abstract][Full Text] [Related]
10. New chemotype of selective and potent inhibitors of human delta 24-dehydrocholesterol reductase.
Müller C; Hemmers S; Bartl N; Plodek A; Körner A; Mirakaj V; Giera M; Bracher F
Eur J Med Chem; 2017 Nov; 140():305-320. PubMed ID: 28964935
[TBL] [Abstract][Full Text] [Related]
11. A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR(-/-) mice.
Peng D; Hiipakka RA; Xie JT; Dai Q; Kokontis JM; Reardon CA; Getz GS; Liao S
Br J Pharmacol; 2011 Apr; 162(8):1792-804. PubMed ID: 21232031
[TBL] [Abstract][Full Text] [Related]
12. CCAAT/enhancer binding protein β deletion increases mitochondrial function and protects mice from LXR-induced hepatic steatosis.
Rahman SM; Choudhury M; Janssen RC; Baquero KC; Miyazaki M; Friedman JE
Biochem Biophys Res Commun; 2013 Jan; 430(1):336-9. PubMed ID: 23159614
[TBL] [Abstract][Full Text] [Related]
13. Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands.
Yang C; McDonald JG; Patel A; Zhang Y; Umetani M; Xu F; Westover EJ; Covey DF; Mangelsdorf DJ; Cohen JC; Hobbs HH
J Biol Chem; 2006 Sep; 281(38):27816-26. PubMed ID: 16857673
[TBL] [Abstract][Full Text] [Related]
14. How essential is cholesterol?
Stevenson J; Brown AJ
Biochem J; 2009 May; 420(2):e1-4. PubMed ID: 19426142
[TBL] [Abstract][Full Text] [Related]
15. Feedback modulation of cholesterol metabolism by the lipid-responsive non-coding RNA LeXis.
Sallam T; Jones MC; Gilliland T; Zhang L; Wu X; Eskin A; Sandhu J; Casero D; Vallim TQ; Hong C; Katz M; Lee R; Whitelegge J; Tontonoz P
Nature; 2016 Jun; 534(7605):124-8. PubMed ID: 27251289
[TBL] [Abstract][Full Text] [Related]
16. Dehydrocholesterol Reductase 24 (DHCR24): Medicinal Chemistry, Pharmacology and Novel Therapeutic Options.
Müller C; Hank E; Giera M; Bracher F
Curr Med Chem; 2022; 29(23):4005-4025. PubMed ID: 34781860
[TBL] [Abstract][Full Text] [Related]
17. Cell-specific discrimination of desmosterol and desmosterol mimetics confers selective regulation of LXR and SREBP in macrophages.
Muse ED; Yu S; Edillor CR; Tao J; Spann NJ; Troutman TD; Seidman JS; Henke A; Roland JT; Ozeki KA; Thompson BM; McDonald JG; Bahadorani J; Tsimikas S; Grossman TR; Tremblay MS; Glass CK
Proc Natl Acad Sci U S A; 2018 May; 115(20):E4680-E4689. PubMed ID: 29632203
[TBL] [Abstract][Full Text] [Related]
18. LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse.
Quinet EM; Basso MD; Halpern AR; Yates DW; Steffan RJ; Clerin V; Resmini C; Keith JC; Berrodin TJ; Feingold I; Zhong W; Hartman HB; Evans MJ; Gardell SJ; DiBlasio-Smith E; Mounts WM; LaVallie ER; Wrobel J; Nambi P; Vlasuk GP
J Lipid Res; 2009 Dec; 50(12):2358-70. PubMed ID: 19318684
[TBL] [Abstract][Full Text] [Related]
19. Low dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levels.
van der Hoorn J; Lindén D; Lindahl U; Bekkers M; Voskuilen M; Nilsson R; Oscarsson J; Lindstedt E; Princen H
Br J Pharmacol; 2011 Apr; 162(7):1553-63. PubMed ID: 21175581
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis.
Waterham HR; Koster J; Romeijn GJ; Hennekam RC; Vreken P; Andersson HC; FitzPatrick DR; Kelley RI; Wanders RJ
Am J Hum Genet; 2001 Oct; 69(4):685-94. PubMed ID: 11519011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
